Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer ...

The all-or-nothing strategy has landed the ‘pride of the pharmaceutical industry' in a situation that deteriorated rapidly.

Starboard Value LP underperformed peers in 2024, a year in which Jeff Smith’s activist firm was frustrated with large ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...

Pfizer Ltd., on Friday said its board has approved signing a marketing and supply agreement with Mylan Pharmaceuticals Pvt. Ltd. for two of its brands -- Ativan and Pacitane. Ativan is used for the ...

As portions of the Skyline elevated rail continue construction, HART board members deal with internal legal conflict. But the city’s Department of the Corporation Counsel disagreed, proposing ...

The board of directors of the company at their meeting held on Friday approved the proposal to enter into a marketing and supply agreement with Mylan Pharmaceuticals for the marketing and sale of ...

Pfizer Ltd's board has approved a five-year marketing and supply agreement with Mylan Pharmaceuticals for the brands Ativan and Pacitane, targeting the treatment of anxiety disorders and Parkinsonism.

ByInvesting.com • Oct 09, 2024 Pfizer CEO plans to meet activist investor Starboard, FT reports (Reuters) -Pfizer CEO Albert Bourla plans to meet key executives of activist hedge fund Starboard ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...